GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (NAS:AVGR) » Definitions » Cyclically Adjusted Price-to-FCF

Avinger (Avinger) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avinger Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Avinger Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Avinger's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Cyclically Adjusted Price-to-FCF Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avinger Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avinger's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Avinger's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avinger's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Avinger's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Avinger's Cyclically Adjusted Price-to-FCF falls into.



Avinger Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Avinger's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Avinger's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-3.205/131.7762*131.7762
=-3.205

Current CPI (Mar. 2024) = 131.7762.

Avinger Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 -89,640.000 100.684 -117,321.822
201509 -125,590.000 100.392 -164,852.333
201512 -118,080.000 99.792 -155,925.037
201603 -164,940.000 100.470 -216,334.029
201606 -154,220.000 101.688 -199,851.561
201609 -102,027.273 101.861 -131,991.305
201612 -57,373.684 101.863 -74,222.321
201703 -66,460.000 102.862 -85,141.541
201706 -226.600 103.349 -288.928
201709 -174.700 104.136 -221.070
201712 -19,911.538 104.011 -25,226.796
201803 -6,877.000 105.290 -8,606.983
201806 -2,234.500 106.317 -2,769.590
201809 -772.750 106.507 -956.091
201812 -335.750 105.998 -417.403
201903 -434.214 107.251 -533.509
201906 -172.571 108.070 -210.427
201909 -158.538 108.329 -192.852
201912 -100.771 108.420 -122.479
202003 -101.429 108.902 -122.734
202006 -37.637 108.767 -45.599
202009 -14.121 109.815 -16.945
202012 -11.180 109.897 -13.406
202103 -15.784 111.754 -18.612
202106 -11.786 114.631 -13.549
202109 -11.390 115.734 -12.969
202112 -11.154 117.630 -12.495
202203 -19.055 121.301 -20.701
202206 -11.489 125.017 -12.110
202209 -7.717 125.227 -8.121
202212 -5.359 125.222 -5.640
202303 -7.686 127.348 -7.953
202306 -5.420 128.729 -5.548
202309 -5.057 129.860 -5.132
202312 -2.648 129.419 -2.696
202403 -3.205 131.776 -3.205

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avinger  (NAS:AVGR) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Avinger Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Avinger's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger (Avinger) Business Description

Traded in Other Exchanges
N/A
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Executives
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Nabeel Paul Subainati officer: Vice President, Finance 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
James Cullen director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Mark Weinswig officer: Chief Financial Officer EMCORE CORP, 10420 RESEARCH ROAD, SE, ALBUQUERQUE NM 87123
Himanshu Patel officer: Chief Technology Officer C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Jeffrey M Soinski director, officer: President and CEO 585 WEST 500 SOUTH, BOUNTIFUL UT 84010
Tamara Elias director 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Simpson John B Ph D Md director, 10 percent owner C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
Matthew Ferguson officer: CBO, CFO & Treasurer C/O FOXHOLLOW TECHNOLOGIES, INC., 740 BAY ROAD, REDWOOD CITY CA 94063
John D. Simpson officer: Sr. VP, Sales & Marketing C/O AVINGER, INC., 400 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063